Onyx connects with Idis to introduce carfilzomib to Europe
This article was originally published in Scrip
Executive Summary
Onyx Pharmaceuticals has forged a partnership with UK company Idis to initiate a managed-access program for carfilzomib in certain countries in Europe for multiple myeloma patients.